Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 27, 2017
Pharmacy Choice - News - Generic Drugs - March 27, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 68     Next >>     Go To Page:

3/27/17 - Altasciences Clinical Research Companies Recognized for Leadership
By a News Reporter-Staff News Editor at Clinical Trials Week Altasciences Clinical Research proudly announces that its companies, Algorithme Pharma and Vince& Associates Clinical Research, have each been awarded multiple 2017 CRO Leadership Awards. This is the fourth consecutive year that Algorithme Pharma has been recognized by the industry.
3/27/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 13634) - Workshop
EVENT: Health and Human Services Department; Food and Drug Administration holds a workshop on "Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives," focusing on the current status of regulatory science initiatives for generic drugs and an opportunity for public input on research priorities in this area. LOCATION: FDA White Oak
3/27/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 14734) - Conference
EVENT: Health and Human Services Department; Food and Drug Administration holds a conference of the Center for Drug Evaluation and Research on "FDA CDER Small Business and Industry Assistance Regulatory Education for Industry Generic Drugs Forum," to provide direct, relevant, and helpful information on the key aspects of the generic drug developmen
3/27/17 - Impax Board of Directors Appoints Paul M. Bisaro President and CEO
Impax Laboratories, Inc. today announced that its Board of Directors has appointed Paul M. Bisaro as Impax's President and Chief Executive Officer and a member of the Company's Board, effective March 27, 2017. "We are pleased to have Paul, a highly respected and accomplished leader, with a strong track record of delivering superior shareholder r
3/27/17 - Lannett Announces Passing Of Former Chairman And Chief Executive Officer William Farber
Lannett Company, Inc. today announced that its former chairman and chief executive officer William Farber, R. Ph., has passed away from natural causes. Mr. Farber served as the company's CEO from 1991 until 2006, chairman from 1991 to 2011 and chairman emeritus from 2011 until 2014.. In 1991, Bill purchased a struggling Lannett Company, one of th
3/27/17 - Recent Findings from S. Francescon and Co-Researchers Yields New Information on Clinical Oncology (Biosimilar Oncology Drugs in Europe: Regulatory...
Recent Findings from S. Francescon and Co-Researchers Yields New Information on Clinical Oncology. According to news reporting originating from Aviano, Italy, by NewsRx correspondents, research stated, "The introduction in clinical practice of pharmaceutical products known as biosimilars, as part of a more complex series of progress in the field of
3/27/17 - Research and Markets has Announced the Launch of their Teva Pharmaceuticals Market Research Portal
By a News Reporter-Staff News Editor at Pharma Business Week The new research portal is an invaluable resource for anyone seeking company research on Teva Pharmaceuticals and their activities within the generic drug, active pharmaceutical ingredient and proprietary pharmaceuticals markets, providing comprehensive research on their market position
3/26/17 - EU questions authenticity 300 generic drugs tested by Indian firm [India Infoline News Service]
Europe medicine regulator has recommended the suspension of over 300 generic drug approvals& drug applications as due to unreliable tests been taken by Indian contract research firm Micro Therapeutic Research Labs. Europe medicine regulator has recommended the suspension of over 300 generic drug approvals& drug applications as due to unreliable tes
3/25/17 - EU recommends suspending hundreds of drugs tested by Indian firm [Jerusalem Post (Israel)]
Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs. The decision, announced by the European Medicines Agency on its website, is the latest blow for India's drug-testing industry,
3/25/17 - French Firm Takes Over Nigerian Drug Manufacturing Company, Swipha [Daily Independent (Nigeria)]
A French pharmaceutical company specialised in generic and biosimilar medicines, and a subsidiary of Servier, on Friday announced the takeover of all the activities of Swipha, a Nigerian company that manufactures and distributes pharmaceutical products known for their quality. This is an important step forward in the internationalisation of the Fre
3/25/17 - Lupin gets approval in inhalation space [Syrian Arab News Agency]
It received final approval for its Tobramycin Inhalation Solution USP, 300 mg/5 ml from US Food and Drug Administration to market a generic version of Novartis Pharmaceuticals` TOBI 300 mg/5 ml. Lupin has the fifth largest pipeline of ANDA filings pending approval with US FDA 134 product filings pending approval. Cumulative Filings with the US FD
3/25/17 - Pharma & Healthcare Newsletter March 20 to March 24, 2017 [India Infoline News Service]
This week, "The US Food and Drug Administration has added one more clause in its import alert given to the drug maker, Divi's Laboratories Limited." Pharma Major Lupin Limited announced today that it has received final approval for its Tobramycin Inhalation Solution USP, 300 mg/5 ml from the United States Food and Drug Administration to market a ge
3/25/17 - Provision Of Amgros 2017-1.851.a. [TendersInfo (India)]
Contract notice: Provision of Amgros 2017-1.851. a. Contract number includes the following products: Invitation to tender: 1, ATC code: J02AX04, Generic Name: Caspofungin, Pharmaceutical form: Infusion Strength: 50 mg, Unit Value: 50 mg, Quantity in Units 2 550th Invitation to tender: 1, ATC code: J02AX04, Generic Name: Caspofungin, Pharmaceutical
3/24/17 - Amring Pharmaceuticals Acquired Six ANDAs
By a News Reporter-Staff News Editor at Drug Week Amring Pharmaceuticals Inc., a generic pharmaceutical company, announced that it acquired six ANDAs from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture between Luitpold Pharmaceuticals, Inc. and Alphagen Laboratories Inc. Acquired ANDAs include niche otic and ophthalmic...
3/24/17 - Biogaran takes over Swipha's activities in Nigeria to produce quality generic medicines for the local market
LAGOS, Nigeria Biogaran, a French pharmaceutical company specialized in generic and biosimilar medicines, and a subsidiary of Servier, today announced the takeover of all the activities of Swipha, a Nigerian company that manufactures and distributes pharmaceutical products known for their quality. This is an important step forward in the...
3/24/17 - Biogaran takes over Swipha's activities in Nigeria to produce quality generic medicines for the local market A strong commitment to make quality, accessible, affordable medicines available to patients
Biogaran, a French pharmaceutical company specialized in generic and biosimilar medicines, and a subsidiary of Servier, today announced the takeover of all the activities of Swipha, a Nigerian company that manufactures and distributes pharmaceutical products known for their quality. This is an important step forward in the internationalization of t
3/24/17 - Biosimilar of costly inflammatory bowel disease therapy found safe and effective
By a News Reporter-Staff News Editor at Drug Week Treatment of Crohn's disease and ulcerative colitis has been greatly improved by the introduction of biologic therapies such as infliximab, but at considerable cost. CT-P13 has been recently approved in the United States, the European Union, Australia, Canada, Japan, and many other countries.
3/24/17 - ELEVEN BIOTHERAPEUTICS, INC. - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the notes to those financial statements appearing in this Annual Report on Form 10- K. This discussion contains forward-looking statements that involve risks and uncertainties.
3/24/17 - FDA Approves First-ever Merkel Cell Carcinoma Drug, HTGM Riding High, FLXN Soars
THOUSAND OAKS- The European Commission has approved Amgen's AMGEVITA as a biosimilar to Humira for the treatment of certain inflammatory diseases. AMGEVITA is Amgen's first biosimilar to be approved by the European Commission. AMGEVITA was approved in the United States by the FDA last September.
3/24/17 - French Firm Takes Over Nigerian Drug Manufacturing Company, Swipha
Biogaran, a French pharmaceutical company specialised in generic and biosimilar medicines, and a subsidiary of Servier, on Friday announced the takeover of all the activities of Swipha, a Nigerian company that manufactures and distributes pharmaceutical products known for their quality. This is an important step forward in the internationalisation
3/24/17 - Global Biologics and Biosimilars Market-Pfizer, Changchun High Tech, Dong Bao, Eli Lilly, GanleeRoche
Pune, Mahrashtra 03/23/2017 The motive of this strategic research report entitled "Global Biologics and Biosimilars Market 2017-2022" is to provide company officials, industry investors, and Biologics and Biosimilars industry members with consequential insights to enable them make reliable strategic decisions regarding the opportunities in th
3/24/17 - Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine
Release date- 23032017- WINNIPEG- Medicure Inc., a leading Canadian specialty pharmaceutical company, is pleased to announce that its majority-owned subsidiary, Apicore Inc., has received final approval from the U.S. Food and Drug Administration for the Company's abbreviated new drug application for tetrabenazine tablets in the 12.5 mg and 25 mg st
3/24/17 - Mylan Launches Generic Pristiq Tablets
By a News Reporter-Staff News Editor at Drug Week- Mylan N.V., announced the U.S. launch of Desvenlafaxine Extended-release Tablets, 50 mg and 100 mg, a generic version of Pfizer's Pristiq Tablets. Desvenlafaxine Extended-release Tablets, 50 mg and 100 mg, had U.S. sales of approximately $853 million for the 12 months ending January 31, 2017,
3/24/17 - NuGlobal Healthcare, LLC: Founded to innovate and revolutionize generic pharmaceutical industry using proprietary niche technologies and decades.
NuGlobal Healthcare, LLC is founded to innovate and revolutionize generic pharmaceutical industry using proprietary niche technologies and decades of value driven pharmaceutical experience to deliver quality drug products focusing patients unmet needs and affordability by de-risking and maximizing investor capital. NuGlobal Healthcare jointly...
3/24/17 - PCI Synthesis Wins Big at 2017 Life Science Leader Magazine CMO Leadership Awards [Sudan Tribune]
PCI Synthesis, Inc., a pharmaceutical manufacturer of new chemical entities, generic active pharmaceutical ingredients, and other specialty chemical products, today announced that it was recognized as the "Top Overall Performer" in every category the awards are given: Quality, Reliability, Capabilities, Expertise, Compatibility, and Development.
Articles(s): 1 - 25 of 68     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415